Obinutuzumab in Rituximab-resistant and recurrent membranous nephropathy: a case-series
This case-series supports the existing evidence in favour of Obinutuzumab for treatment-resistant PLA2R-associated membranous nephropathy. To our knowledge it is the first reported use of Obinutuzumab in sarcoidosis-associated membranous nephropathy.
Authors
- Alan Pham (ORCID: https://orcid.org/0000-0002-1854-5442)
- Holly Hutton
- Gopal Basu (ORCID: https://orcid.org/0000-0002-8586-8743)
- Krita Sridharan (ORCID: https://orcid.org/0000-0002-8115-1411)
- Scott G. Wilson (ORCID: https://orcid.org/0000-0002-0357-1373)
Institutions
- The Alfred Hospital (AU)
- St Vincent's Hospital Melbourne (AU)
- Melbourne Clinic (AU)
- Monash University (AU)
Publication Details
- Journal
- Journal of Nephrology
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1007/s40620-025-02224-6
- Citations
- 7
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 10.02
Funders
- St Vincent's Hospital Melbourne